Article

Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype.

Department of Histology, University of Medicine and Pharmacy Craiova, Petru Rares Street 2, 200349 Craiova-Dolj, Romania. .
Journal of Histochemistry and Cytochemistry (Impact Factor: 2.4). 03/2009; 57(6):567-75. DOI: 10.1369/jhc.2009.953240
Source: PubMed

ABSTRACT Double or multiple antigen labeling in IHC classically relies on the existence of primary antibodies raised in different species or of different IgG isotypes to ensure the specific labeling with the secondary detection systems. However, suitable pairs of primary antibodies are not always available or the best choice (e.g., as diagnostic tools). During the last few years, several methods have been proposed to overcome this, but none of them offers the flexibility needed for reliable double or multiple enzymatic or fluorescent IHC. We present here a procedure that elutes the antibodies after a first round of immunolabeling, which, in combination with precipitation-based detection systems, allows multiple IHC rounds even for primary antibodies raised in the same species and IgG isotype. Compared with other proposed methods, this procedure ensures a reliable enzymatic or fluorescent staining without cross-reactivity and without loss of tissue antigenicity, thus offering a flexible tool for colocalization studies and pathological diagnosis. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials.

1 Follower
 · 
144 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Krüppel-like factor 5 (KLF5) is a pro-proliferative transcription factor that is expressed in dividing epithelial cells of the intestinal crypt. Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) has been identified as a stem cell marker in both small intestinal and colonic epithelial cells. To determine whether KLF5 regulates proliferation of intestinal stem cells, we investigated the effects of Klf5 deletion specifically from the intestinal stem cells in adult mice. Mice with inducible intestinal stem cell-specific deletion of Klf5 (Lgr5-Klf5fl/fl) were injected with tamoxifen for 5 consecutive days to induce Lgr5-driven Cre expression. Intestinal and colonic tissues were examined by immunohistochemistry at various time points up to 112 days following start of tamoxifen treatment. Klf5 is co-localized in the crypt-based columnar (CBC) cells that express Lgr5. By 11 days following the start of tamoxifen treatment, Lgr5-positive crypts from which Klf5 was deleted exhibited a loss of proliferation that was accompanied by an increase in apoptosis. Beginning at 14 days following the start of tamoxifen treatment, both Klf5 expression and proliferation were re-established in the transit-amplifying epithelial cells but not in the Lgr5-positive CBC cells. By 112 days post-treatment, up to 90% of the Lgr5-positive cells from which Klf5 was deleted were lost from the intestinal crypts. These results indicate a critical role for KLF5 in the survival and maintenance of intestinal stem cells.
    Stem Cell Research 11/2014; 14(1). DOI:10.1016/j.scr.2014.10.008 · 3.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. Huntington's disease (HD) is caused by a genetically encoded pathological protein (mutant huntingtin (mHtt)), which is thought to exert its effects in a cell-autonomous manner. Here, we tested the hypothesis that mHtt is capable of spreading within cerebral tissue by examining genetically unrelated fetal neural allografts within the brains of patients with advancing HD. Methods. The presence of mHtt aggregates within the grafted tissue was confirmed using 3 different types of microscopy (brightfield, fluorescence and electron), 2 additional techniques consisting of western immunoblotting and infrared spectroscopy, and 4 distinct antibodies targeting different epitopes of mHtt aggregates. Results. We describe the presence of mHtt aggregates within intracerebral allografts of striatal tissue in three HD patients who received their transplants approximately a decade earlier and then died secondary to the progression of their disease. The mHtt+ aggregates were observed in the extracellular matrix of the transplanted tissue while in the host brain they were seen in neurons, neuropil, extracellular matrix and blood vessels. Interpretation. This is the first demonstration of the presence of mHtt in genetically normal and unrelated allografted neural tissue transplanted into the brain of affected HD patients. These observations raise questions on protein spread in monogenic neurodegenerative disorders of the central nervous system characterized by the formation of mutant protein oligomers/aggregates. ANN NEUROL 2014. © 2014 American Neurological Association
    Annals of Neurology 07/2014; 76(1). DOI:10.1002/ana.24174 · 11.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: CD25, the alpha subunit of the interleukin-2 (IL-2) receptor, is a canonical marker of regulatory T cells (Tregs) and hence has been implicated in immune suppression in cancer. However, CD25 is also required for optimal expansion and activity of effector T cells in peripheral tissues. Thus, we hypothesized that CD25, in addition to demarcating Tregs, might identify effector T cells in cancer. To investigate this, we used multi-parameter flow cytometry and immunohistochemistry to analyze tumor-infiltrating lymphocytes (TIL) in primary high-grade serous carcinomas (HGSC), the most common and fatal subtype of ovarian cancer. CD25 was expressed primarily by CD4+ TIL, with negligible expression by CD8+ TIL. In addition to conventional CD25+FoxP3+ Tregs, we identified a subset of CD25+FoxP3- T cells that comprised up to 13% of CD4+ TIL. In tumors with CD8+ TIL, CD25+FoxP3- T cells showed a strong positive association with patient survival (HR 0.56, P=0.02), which exceeded the negative effect of Tregs (HR 1.55, P=0.09). Amongst CD4+ TIL subsets, CD25+FoxP3- cells expressed the highest levels of PD-1. Moreover, after in vitro stimulation they failed to produce common T helper cytokines (IFN-γ, TNF-α, IL-2, IL-4, IL-10 or IL-17A), suggesting they were functionally exhausted. In contrast, the more abundant CD25-FoxP3- subset of CD4+ TIL expressed low levels of PD-1 and produced T helper 1 cytokines, yet conferred no prognostic benefit. Thus, CD25 identifies a subset of CD4+FoxP3- TIL that, despite being exhausted at diagnosis, have a strong, positive association with patient survival and warrant consideration as effector T cells for immunotherapy. Copyright © 2014, American Association for Cancer Research.
    12/2014; 3(3). DOI:10.1158/2326-6066.CIR-14-0146